Drug Therapy in Lupus Nephropathy - Related Studies

Drug Therapy in Lupus Nephropathy

This study has been completed.

Study NCT00001212. Last updated on April 8, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Nephrotic Syndrome
		Systemic Lupus Erythematosus

2	Additional conditions recognized in this trial
		Lupus Erythematosus, Systemic
		Syndrome

3	More general conditions related to this trial
		Autoimmune Diseases
		Connective Tissue Diseases
		Disease
		Immune System Diseases
		Kidney Diseases
		Nephrosis
		Pathologic Processes
		Urologic Diseases

4	Interventions listed in this trial
		prednisone
		cyclophosphamide
		cyclosporin A

5	Additional drug interventions recognized in this trial
		Cyclosporine
		Cyclosporins

6	More general drug interventions related to this trial
		Alkylating Agents
		Anti-Infective Agents
		Anti-Inflammatory Agents
		Antifungal Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)